Author

Aidan Reaver

Cognition Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:matrix factorization· 1

Frequent Co-Authors

Anthony O. CaggianoiD· 2 shared Britney N. LizamaiD· 2 shared Gary C. Look· 2 shared Mary E. HambyiD· 2 shared Duc M. DuongiD· 1 shared Hilary A. North· 1 shared Kiran Pandey· 1 shared Nicholas T. SeyfriediD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Anthony O. CaggianoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sigma-2 Receptor Modulators Alter Low-density Lipoprotein Receptor-mediated Lipid Uptake in Retinal Pigment Epithelial Cells

Britney N. Lizama, Aidan Reaver, Gary C. Look, Anthony O. Caggiano, Mary E. Hamby

This study shows that sigma-2 receptor modulators increase LDL uptake in RPE cells via TMEM97 and LDLR, supporting their potential therapeutic use in dry AMD.

Experimental Eye Research · Feb 25, 2026Peer-reviewedCell Biology

Multi-omics comparative analyses of synucleinopathy models reveal distinct targets and relevance for drug development

Britney N. Lizama, Rick S. Shin, Hilary A. North, Gary C. Look, Aidan Reaver, Kiran Pandey, Duc M. Duong, Nicholas T. Seyfried, Anthony O. Caggiano, Mary E. Hamby

The paper compares two rat synucleinopathy models using multi-omics data to identify disease mechanisms and drug targets relevant to Parkinson's disease.

bioRxiv · Jun 20, 2025 · PreprintNeuroscience